Stephan Stilgenbauer

26PUBLICATIONS
215CO-AUTHORS
AutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|May 27, 2026
Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

|Apr 23, 2026
The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia.

|Mar 12, 2026
Short and complex-Telomeres and genomes in CLL.

Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer

|Feb 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia.

Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia

|Feb 08, 2026
Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts.

Albert Kallon Koroma, Karmveer Singh, Yongfang Wang

|Jan 16, 2026
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.

Linda Simon, Vladan Vucinic, Kai Rejeski

Pageof 5

Frequent Collaborators

5 joint publications

Paolo Ghia

4 joint publications

Michael Hallek

3 joint publications

Othman Al-Sawaf

3 joint publications

Sébastien Hergalant